 Alkido Pharma NASDAQ: AIKI shares are trading higher after the company announced it executed a Patent License Agreement for technology that covers the use of psilocybin for cancer applications. AIkido Pharma is engaged in the development of small-molecule anti-cancer therapeutics. 